Follow
Maestro Roberta
Maestro Roberta
Director, Unit of Experimental Oncology 1, CRO Aviano National Cancer Institute (Italy)
Verified email at cro.it
Title
Cited by
Year
Beyond self‑eating: Emerging autophagy‑independent functions for the autophagy molecules in cancer
G Tedesco, M Santarosa, R Maestro
International Journal of Oncology 64 (6), 1-13, 2024
12024
Fusion transcriptome profiling defines the monoclonal origin of multifocal epithelioid haemangioma of bone
C Errani, I De Benedictis, A Righi, B Valenti, E Del Savio, D Baldazzi, ...
Histopathology 83 (5), 743-755, 2023
12023
Multi-omics Quality Assessment in Personalized Medicine through EATRIS
EATRIS Plus Multi-omics working group and stakeholders (in alphabetical ...
bioRxiv, 2023.10. 25.563912, 2023
2023
Routine molecular profiling in both resectable and unresectable pancreatic adenocarcinoma: relevance of cytologic samples
M Redegalli, G Grassini, G Magliacane, L Pecciarini, MS Lena, CE Smart, ...
Clinical Gastroenterology and Hepatology 21 (11), 2825-2833, 2023
132023
In Silico Identification of a BRCA1: miR-29: DNMT3 Axis Involved in the Control of Hormone Receptors in BRCA1-Associated Breast Cancers
M Santarosa, D Baldazzi, M Armellin, R Maestro
International Journal of Molecular Sciences 24 (12), 9916, 2023
2023
CINSARC in high‐risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG‐STS 1001 study
AM Frezza, S Stacchiotti, F Chibon, JM Coindre, A Italiano, C Romagnosa, ...
Cancer Medicine 12 (2), 1350-1357, 2023
162023
Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum …
S Stacchiotti, AM Frezza, GD Demetri, JY Blay, J Bajpai, GG Baldi, ...
Cancer treatment reviews 110, 102455, 2022
132022
ISG15 as a prognostic biomarker in solitary fibrous tumour
JLM Hernandez, DS Moura, M Lopez-Alvarez, P Sanchez-Bustos, ...
European Journal of Cancer 174, S108, 2022
2022
Tazemetostat and doxorubicin in patient-derived preclinical models of epithelioid sarcoma (ES)
S Pasquali, N Arrighetti, V Zuco, M Tortoreto, C Soffientini, L Sigalotti, ...
European Journal of Cancer 174, S68, 2022
2022
Beyond SMARCB1 loss: recent insights into the pathobiology of epithelioid sarcoma
E Del Savio, R Maestro
Cells 11 (17), 2626, 2022
142022
ISG15 as a prognostic biomarker in solitary fibrous tumour
JL Mondaza-Hernandez, DS Moura, M Lopez-Alvarez, P Sanchez-Bustos, ...
Cellular and Molecular Life Sciences 79 (8), 434, 2022
52022
MET inhibition sensitizes rhabdomyosarcoma cells to NOTCH signaling suppression
C Perrone, S Pomella, M Cassandri, M Pezzella, GM Milano, M Colletti, ...
Frontiers in Oncology 12, 835642, 2022
72022
Interference of p53: Twist1 interaction through competing nanobodies
S D'Agostino, E Mazzega, K Praček, S Piccinin, F Pivetta, M Armellin, ...
International journal of biological macromolecules 194, 24-31, 2022
52022
The autophagic route of e-cadherin and cell adhesion molecules in cancer progression
M Santarosa, R Maestro
Cancers 13 (24), 6328, 2021
172021
mTORC1 promotes malignant large cell/anaplastic histology and is a targetable vulnerability in SHH-TP53 mutant medulloblastoma
V Conti, M Cominelli, V Pieri, AL Gallotti, I Pagano, M Zanella, ...
JCI insight 6 (23), 2021
52021
Filling the gap: A thorough investigation for the genetic diagnosis of unsolved polyposis patients with monoallelic MUTYH pathogenic variants
A Dell’Elice, G Cini, M Fornasarig, F Armelao, D Barana, F Bianchi, ...
Molecular Genetics & Genomic Medicine 9 (12), e1831, 2021
22021
Whole genome and exome sequencing reference datasets from a multi-center and cross-platform benchmark study
Y Zhao, LT Fang, T Shen, S Choudhari, K Talsania, X Chen, J Shetty, ...
Scientific data 8 (1), 296, 2021
242021
1817P In silico identification of a BRCA1/miR-29/DNMT3A-3B axes involved in estrogen receptor expression of BRCA1-associated breast cancers
M Santarosa, M Armellin, D Baldazzi, R Maestro
Annals of Oncology 32, S1232, 2021
2021
Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing
W Xiao, L Ren, Z Chen, LT Fang, Y Zhao, J Lack, M Guan, B Zhu, ...
Nature biotechnology 39 (9), 1141-1150, 2021
922021
Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing
LT Fang, B Zhu, Y Zhao, W Chen, Z Yang, L Kerrigan, K Langenbach, ...
Nature biotechnology 39 (9), 1151-1160, 2021
452021
The system can't perform the operation now. Try again later.
Articles 1–20